Allergenicity Assessment

At GVRP, our pharmacology services are designed to advance your drug discovery and development programs with precision and expertise. Our state-of-the-art facilities and experienced scientific team provide robust data across a wide range of therapeutic areas.

In partnership with

Elevating Product Safety and Regulatory Compliance

The GARD® (Genomic Allergen Rapid Detection) Assay suite, developed by SenzaGen, is a comprehensive set of in vitro tests designed to predict specific hazards of chemical substances. By analyzing the relative expression levels of genomic biomarker signatures, GARD® accurately identifies potential sensitizers, enabling companies to make informed decisions about their products.
GVRP is the authorized distributor of SenzaGen’s cutting-edge GARD® Assay services in India. Our partnership brings you a transformative solution for safety assessment, ensuring the development of safer, ethical, and more sustainable products.

GARD® Assay services

  • GARD®skin: A skin sensitization assay that provides a binary answer for the safety assessment of chemicals. Approved by OECD for regulatory testing. As a new method included in OECD TG 442E for in vitro skin sensitization, GARD®skin supports discrimination of skin sensitizers and non-sensitizers in accordance with the UN GHS.
  • GARD®potency: An add-on assay to GARD™skin, subcategorizing sensitizers according to CLP/GHS classifications, determining their potency. It is an approved test method included in the OECD Test Guideline Program (TGP 4.106). It has gained recognition and acceptance from regulatory bodies such as the European Chemicals Agency (ECHA). As a result, the results obtained from GARDpotency can be utilized as weight-of-evidence in REACH dossiers for sub-categorization of confirmed skin sensitizers into 1A or 1B according to the GHS/CLP system
  • GARD®air: A respiratory sensitization assay that offers a binary answer for the safety assessment of chemicals.
  • GARD®skin Medical Device: Offers an in vitro alternative for skin sensitization testing as a part of the Biological Evaluation of Medical Devices according to ISO 10993
  • GARD®skin Dose-Response: A skin sensitization testing assay that provides quantitative potency assessment.

How does GARD® Assay work?

These assays are based on the Genomic Allergen Rapid Detection (GARD) platform, which uses SenzaCell, a human myeloid leukemia cell line acting as an in vitro model of human Dendritic Cells (DCs). By examining the transcriptional responses of SenzaCells following exposure to chemicals, the company has identified a set of genes relevant to specific hazard properties.
Using NanoString nCounter technology, the expression levels of these genes are quantified to derive a decision value (DV) from a Support Vector Machine prediction model. This technology provides accurate and reliable results for safety assessment.

Our Promise

At GVRP, we strive for innovation through collaboration. By integrating the GARD® Assay suite into your workflows, you can enhance product safety, ensure regulatory compliance, and mitigate risks associated with sensitization issues. Experience the exceptional predictability of GARD® Assay services and benefit from the advanced in vitro testing methods that reflect human biology accurately.

Join us in shaping a future where safety standards are elevated, regulatory compliance is facilitated, and innovative solutions are fostered.

Related Links

Safety Assessment Platform

Accelerate decision making through a full-suite and customized safety assessment solutions.

Read More

About Us

GVRP is your strategic partner, advancing the Advancing across the industries like biopharma ,Agritech, Medtech, Speciality Chemicals, Industrial chemicals by providing comprehensive, flexible, and cost-effective solutions for every stage of the research and development process.

Read More

Infrastructure

GVRP is equipped with robust Facility to ensure smooth delivery of service across spectrum in the drug Discovery continuum.

Read More

Quick Links

Connect With Us

Corporate Office:

Registered Office: Sy.No.403/1(Old), 120 (New), 4th Floor, Niharika Jubilee One, Road No.1, Jubilee Hills, Hyderabad Telangana – 500 033

Research Facility

1st Floor, Touchstone, Synergy Square II, Genome Valley, Shameerpet, Hyderabad, Telangana - 500 078.

Corporate Office:

Registered Office: Sy.No.403/1(Old), 120 (New), 4th Floor, Niharika Jubilee One, Road No.1, Jubilee Hills, Hyderabad Telangana – 500 033

Research Facility

1st Floor, Touchstone, Synergy Square II, Genome Valley, Shameerpet, Hyderabad, Telangana - 500 078.

Copyright 2026 © GV Research Platform

Privacy policy

Site By Green Graffiti

Quick Links

Connect With Us

Icon-email Linkedin

Corporate Office:

Unit L24-02, 24th Floor, ​ One West, Sy. No - 88/AA and 88/E, ​ Nanakramguda Village, ​ Hyderabad, Telangana 500008​

Research Facility

1st Floor, Touchstone, Synergy Square II, Genome Valley, Shameerpet, Hyderabad, Telangana - 500 078.

Corporate Office:

Unit L24-02, 24th Floor, ​ One West, Sy. No - 88/AA and 88/E, ​ Nanakramguda Village, ​ Hyderabad, Telangana 500008​

Research Facility

1st Floor, Touchstone, Synergy Square II, Genome Valley, Shameerpet, Hyderabad, Telangana - 500 078.

Copyright 2026 © GV Research Platform

Privacy policy

Site By Green Graffiti